CorrespondenceReply
References (2)
- et al.
Intralesional macular atrophy in antiVEGF therapy for age-related macular degeneration in the IVAN trial
Ophthalmology
(2019) - et al.
Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians
Br J Ophthalmol
(2017)
Cited by (0)
Financial Disclosures: The authors made the following disclosures: C.B.: Personal fees – Bayer, Allergan, Alimera Sciences, Novartis, outside the submitted work.
U.C.: Speakers bureau, honoraria – Novartis, Roche; Advisory board – Allergan, Bayer.
S.H.: Advisory board – Roche.
B.R.: Grant – British Heart Foundation.
The National Institute for Health Research (NIHR) UK Health Technology Assessment Programme (HTA) Programme funded the IVAN trial (ref: 07/36/01). The sponsor and funding organization had no role in the design or conduct of this research. The views and opinions expressed are those of the authors and do not necessarily reflect those of the UK NIHR, NHS of Department of Health.
© 2019 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology